LIVE TV DownloadNews18 App
News18 English
Powered by cricketnext logo
»
1-min read

Zydus Cadila Gets USFDA Nod For Migraine Drug

Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

IANS

Updated:June 19, 2017, 6:33 PM IST
facebookTwittergoogleskypewhatsapp
Zydus Cadila Gets USFDA Nod For Migraine Drug
Zydus Cadila will sell Eletriptan Hydrobromide tablets used in the treatment of migraine. (Photo courtesy: zyduscadila.com)
Loading...
Mumbai: Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

According to the company, the drug with strengths 20mg and 40mg will be produced at the group's formulations manufacturing facility at the Pharma SEZ (special economic zone) in Ahmedabad.

"The group now has more than 120 approvals and has so far filed over 300 ANDAs (abbreviated new drug applications ) since the commencement of the filing process in FY 2003-04," the firm said in a regulatory filing with the BSE.

Catch the Biggest Newsmakers and the Biggest Newsbreaks on CNN-News18, your favourite English TV news channel. Keep watching CNN-News18 at just 50 Paise per Month. Contact your cable /DTH operator Now!
*Rental / capacity fee of Rs.130/- as charged by cable / DTH operator may apply. **GST extra.

Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp
Most Active
Company Price Change %Gain
Reliance 1,240.75 1.18
Interglobe Avi 1,174.25 5.86
Sun Pharma 421.80 -2.13
ITC 280.60 1.19
Yes Bank 193.60 -1.85
Company Price Change %Gain
KPIT Tech 132.75 -39.09
Reliance 1,239.30 1.11
EID Parry 203.40 0.07
Balaji Telefilm 93.00 5.32
Yes Bank 193.65 -1.85

Live TV

Loading...
Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results